A Preliminary Study of Prophylactic Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 17 May 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain; Dyspnoea
- Focus Therapeutic Use
- 09 May 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
- 04 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.